Tom Huizinga

prof

Leiden University Medical Center

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Immunology Immunology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Tom Huizinga is a Professor at Leiden University Medical Center in the Netherlands. His research primarily focuses on rheumatoid arthritis and includes areas such as the survival of biological DMARDs, the safety and efficacy of various treatment modalities, and the role of AI in literature reviews in rheumatology. He has published several articles investigating the associations of therapeutic agents with disease outcomes and patient safety in rheumatic diseases.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (12)

Rene E.M. Toes

Leiden University Medical Center

NETHERLANDS

View details

Diane van der Woude

Leiden University Medical Center

NETHERLANDS

View details

Patrick Verschueren

Full Professor

Katholieke Universiteit Leuven

BELGIUM

View details

Jacob M. van Laar

Professor of Rheumatology

University Medical Center Groningen

NETHERLANDS

View details

KAREN SALOMON-ESCOTO

Associate Professor

UMass Memorial Medical Center

UNITED STATES

View details

Roy Fleischmann

Clinical Professor of Medicine

University of Texas Southwestern Medical Center

UNITED STATES

View details

Charlotte Teunissen

University of Amsterdam

NETHERLANDS

View details

Robert Landewé

Professor

Amsterdam University Medical Centers

NETHERLANDS

View details

Leendert Trouw

Professor

Leiden University Medical Center

NETHERLANDS

View details

Cees van Kooten

Professor Experimental Nephrology & Transplant Immunology

LUMC

NETHERLANDS

View details

Y K Onno Teng

Leiden University Medical Center

NETHERLANDS

View details

Douglas Veale

Professor

Dublin City University

IRELAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tom Huizinga

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Association Between Abatacept Exposure Levels and Infection Occurrence in Patients With Rheumatoid Arthritis: Post Hoc Analysis of the AVERT-2 Study

Biological DMARD survival in rheumatoid arthritis patients in clinical practice: a METEOR registry data analysis

Ratio between biological and targeted synthetic disease-modifying anti-rheumatic drugs and glucocorticoid use in various countries: results from METEOR

Infliximab use and cervical spine deformity in patients with rheumatoid arthritis

Circulating levels of endogenous complement inhibitors correlate inversely with complement consumption in systemic lupus erythematosus

Is AI-assisted active learning software able to reliably speed-up systematic literature reviews in rheumatology? A real-time comparison of AI-assisted and manual abstract selection

Pathogenic role of anti‐nuclear autoantibodies in systemic sclerosis: Insights from other rheumatic diseases

Acetylated bacterial proteins as potent antigens inducing an anti-modified protein antibody response

Are poor prognostic factors a realistic basis for treatment decisions in patients with rheumatoid arthritis? Lessons from the IMPROVED study

Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: results from the phase 2a IRIS-RA study

Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time?

Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosis

Clinical Efficacy of Sarilumab Versus Upadacitinib Over 12 weeks: An Indirect Treatment Comparison

NT-proBNP and sRAGE levels in early rheumatoid arthritis

Repair of joint damage in patients with rheumatoid arthritis does not relate to previous suppression of inflammation: a subanalysis after 8 years treat-to-target in the BeSt-trial

Presence of SARS-CoV-2 antibodies in patients with COVID-19 like symptoms from the IENIMINI cohort

Patterns of clinical joint inflammation in juvenile idiopathic arthritis

Inducibility or predestination? Queries and concepts around drug-free remission in rheumatoid arthritis

Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies

Frequency of joint inflammation is associated with local joint damage progression in rheumatoid arthritis despite long-term targeted treatment

Collaborators (12)

Rene E.M. Toes

Diane van der Woude

Patrick Verschueren

Jacob M. van Laar

KAREN SALOMON-ESCOTO

Roy Fleischmann

Charlotte Teunissen

Robert Landewé

Leendert Trouw

Cees van Kooten

Y K Onno Teng

Douglas Veale

Make your next move.